Skip main navigation

Obesity a global concern

In this article, we discuss the growing (pardon the pun) problem of obesity and how to safely deliver TIVA to these patients.


  • Complex and multifactorial disease – Abnormal or excessive fat accumulation that may impair health – Genetic predisposition – Ethnic factors – Socioeconomic class (SEC) – Co-morbidities – Nutritional input v energy expenditure
  • Worldwide obesity has increased 3 fold since 1975
  • Affects approximately 15-20% of adults in Europe and 55% in the USA and is associated with the metabolic syndrome (hypertension, hyperlipidaemia, diabetes)
  • Body mass index (BMI) is a simple index – Weight in kilograms (kg) divided by height in metres squared (m2) (kg/m2) – BMI of 25 to 29.9 kg.m−2 is classified as overweight or mildly obese – BMI of 30 to 39.9 kg.m−2 is classified as moderately to severely obese patients – BMI ≥40 kg.m−2 are classified as morbidly obese – BMI in children must be interpreted with reference to age and sex
  • Prevalence of obesity varies with SEC and differs between countries – Developed countries lower SEC increased risk – Developing countries with higher SEC increased risk

TIVA and TCI in obese patients

  • Data has been extrapolated from the non-obese population
  • Inaccurate in the obese
  • Excessive dosing is common
  • Dosing strategies of IV anaesthetics need to account for the changes associated with obesity – Physiological – Pharmacokinetic – Pharmacodynamic
This article is from the free online

Introduction to Using Total Intravenous Anaesthesia (TIVA)

Created by
FutureLearn - Learning For Life

Reach your personal and professional goals

Unlock access to hundreds of expert online courses and degrees from top universities and educators to gain accredited qualifications and professional CV-building certificates.

Join over 18 million learners to launch, switch or build upon your career, all at your own pace, across a wide range of topic areas.

Start Learning now